Status:
TERMINATED
Evaluation of the Effects of Osteoperforation and Piezocorticision on Canine Retraction
Lead Sponsor:
Université de Montréal
Collaborating Sponsors:
University of Michigan
Conditions:
Piezocorticision
Osteoperforation
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The primary objective of this research is to compare the rate of canine retraction following the osteoperforation and piezocorticision procedures in cases of first premolar extractions. The secondary ...
Eligibility Criteria
Inclusion
- Dental and/or skeletal Cl I and II requiring maxillary first premolar extraction.
- Young adults 16 years and older.
- Good overall health.
- Complete adult dentition.
- Cooperative.
- Acceptable hygiene.
- Absence of any periodontal disease (gingivitis, periodontitis).
Exclusion
- Non-cooperative, fearful patients or patients with intellectual disability.
- Patients requiring the regular use of nonsteroidal anti-inflammatory drugs (NSAID).
- Use of antibiotics in the last 6 months.
- Previous or current use of bisphosphonates, corticosteroids or immunosuppressive drugs.
- Smokers.
- Patients suffering from uncontrolled systemic diseases (ex. diabetes type I and II).
- Presence of oral or maxillofacial malformations (ex. cleft palate) or dental pathologies (ex. ankylosis, abscess).
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT03308851
Start Date
January 1 2018
End Date
April 30 2021
Last Update
June 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique d'orthodontie de l'Université de Montréal
Montreal, Quebec, Canada, H3V1H9